VARIABILITY IN LEVELS OF LOW-DENSITY LIPOPROTEINS CHOLESTEROL IN PATIENTS WITH FAMILIAL HYPERCHOLESTEROLEMIA DEPENDING ON AGE AND SEX AND ITS IMPORTANCE IN THE DIAGNOSIS OF THIS DISEASE
https://doi.org/10.20996/1819-6446-2017-13-1-36-44
Abstract
Aim. To study the ranges of low density lipoprotein (LDL) cholesterol depending on the age and gender of patients with familial hypercholesterolemia (FHC) by an example of a sample of patients living in the Republic of Karelia.
Material and methods. Parameters of lipid spectrum of 219 patients (aged 52.5±1.7 years; males 38.3%) with heterozygous FHC were studied before the start of statin therapy. Definite FHC was diagnosed in 102 patients. Lipid profile was estimated by enzymatic calorimetric method. The diagnosis of FHC was established according to the criteria of The Dutch Lipid Clinic Network. Genetic analysis was performed in 102 patients (46.6%); pathogenic mutation in the LDL receptor was identified in 21 patients. The control group consisted of 539 people with the excluded diagnosis of FHC (aged 46.8±0.8 years; males 53.8%).
Results. We determined the level of LDL cholesterol (LDLC) associated with increased frequency of mutations of the LDL receptor in patients with definite FHC; mutation frequency was 3 times higher when LDLC level was more than 6.5 mmol/L. We revealed the following characteristic intervals of the LDLC levels in patients with a definite FHC: up to 20 years old – 4.8-6.2 mmol/l; in patients of 20-29 years old – 5.9-8.2 mmol/l; in the age range of 30-39 years the upper value of the LDLC levels reached 9.6 mmol/l; in individuals of 40-49 years old a stabilization, "plateau", was observed – LDLC level did not differ significantly compared to the previous decade, and was 5.4-9.0 mmol/l. In the age range of 50-59 years the upper LDLC level was up to 11.4 mmol/l. Similar indicators were identified in patients aged 60-69 years. Patients older than 70 years with a definite FHC an upper level of LDLC was higher and reached 12.5 mmol/l. Tendency to increase in the characteristic values of LDLC with age was observed both in men and in women. Specific age-related trends for men (an increase from a plateau by the age of 50 years, with some decrease after 60 years) and women (smooth increase of LDLC levels with age) were demonstrated.
Conclusion. Characteristic values of LDLC levels for the Russian population of patients with FHС were shown; relationship between LDLC levels and detection of mutations of the LDL receptor was analyzed.
About the Authors
V. А. KornevaRussian Federation
Victoria A. Korneva - MD, PhD, Associate Professor, Department of Faculty Therapy, Phthisiology, Infectious Diseases and Epidemiology, Institute of Medicine, Petrozavodsk State University.
Lenina prosp. 33, Petrozavodsk, Republic of Karelia, 185001
T. Yu. Kuznetsova
Russian Federation
Tatiana Y. Kuznetsova - MD, PhD, Associate Professor, Head of Department of Faculty Therapy, Phthisiology, Infectious Diseases and Epidemiology, Institute of Medicine, Petrozavodsk State University.
Lenina prosp. 33, Petrozavodsk, Republic of Karelia, 185001
G. P. Tihova
Russian Federation
Galina P. Tihova - Leading Mathematician, Forest Research Institute of Karelian Research Centre, Russian Academy of Sciences.
Pushkinskaya ul. 11, Petrozavodsk, Republic of Karelia, 185910 R
References
1. Watts G.F., Gidding S., Wierzbicki A.S., et al. Integrated guidance on the care of familial hypercholesterolaemia from the International FH Foundation. Int J Cardiol. 2014;171(3):309-25.
2. Ray K.K., Hovingh G.K. Familial hypercholesterolemia: a common disease. Eur Heart J. 2016;37: 1395-7.
3. Boytsov S.A., Kukharchuk V.V., Karpov Yu.A., et al. Subclinical atherosclerosis as a risk factor of cardiovascular events. Kardiovaskulyarnaya Terapiya i Profilaktika. 2012;11(3):82-6. (In Russ.) [Бойцов С.А, Кухарчук В.В., Карпов Ю.А., и др. Субклинический атеросклероз как фактор риска сердечно-сосудистых осложнений. Кардиоваскулярная Терапия и Профилактика. 2012;11(3):82-6].
4. Karpov Yu.A., Kukharchuk V.V., Boytsov S.A. Consensus statement of the Russian National Atherosclerosis Society (RNAS). Familial hypercholesterolemia in Russia: outstanding issues in diagnosis and management. Ateroskleroz i Dislipidemii. 2015;2(19):5-16. (In Russ.) [Карпов Ю.А., Кухарчук В.В., Бойцов С.А. Заключение совета экспертов Национального общества по изучению атеросклероза (НОА). Семейная гиперхолестеринемия в Российской Федерации: нерешенные проблемы диагностики и лечения. Атеросклероз и Дислипидемии. 2015;2(19):5-16].
5. Huijgen R., Hutten B.A, Kindt I., et al. Discriminative ability of LDL-cholesterol to identify patients with familial hypercholesterolemia: a cross-sectional study in 26,406 individuals tested for genetic FH. Circ Cardiovasc Genet. 2012;5(3):354-9.
6. Malyshev P.P., Rozkova T.A., Solovyeva E.Yu., et al. Phenotypical features of heterozygous form of familial hypercholesterolemia. Terapevticheskiy Arkhiv. 2007;9:34-8. (In Russ.) [Малышев П.П., Рожкова Т.А., Соловьева Е.Ю., и др. Фенотипические особенности гетерозиготной формы семейной гиперхолестеринемии. Терапевтический Архив. 2007;9:34-8].
7. Lipoveckij B.M. Familial hypercholesterolemia in parents and children: frequency of inheritance, clinical manifestations, the severity of atherogenic shift. Rossiyskiy Kardiologicheskiy Zhurnal. 2003;2:30-
8. (In Russ.) [Липовецкий Б.М. Семейная гиперхолестеринемия у родителей и детей: частота наследования, клинические проявления, выраженность атерогенного сдвига. Российский Кардиологический Журнал. 2003;2:30-4].
9. Wald D.S., Bestwick J.P., Wald N.J. Child-parent screening for familial hypercholesterolaemia: screening strategy based on a meta-analysis. BMJ. 2007;335:599.
10. Starr B., Hadfield S. G., Hutten B.A., et al. Development of sensitive and specific ageand gender-specific low-density lipoprotein cholesterol cutoffs for diagnosis of first-degree relatives with familial hypercholesterolaemia in cascade testing. Clin Chem Lab Med. 2008;46:791-803.
11. Mabuchi H., Higashikata T., Nohara A., et al. Cutoff point separatingaffected and unaffected familial hypercholesterolemic patients validated by LDL-receptor genemutants. J Atheroscler Thromb. 2005;12:35-40.
12. Leitersdorf E., Van der Westhuyzen D.R., Coetzee G.A., Hobbs H.H. Two common low density lipoprotein receptor gene mutations cause familial hypercholesterolemia in Afrikaners. J Clin Invest. 1989;84:954-961.
13. Vuorio A.F., Turtola H., Piilahti K.M., et al. Familial hypercholesterolemia in the Finnish north Karelia. A molecular, clinical, and genealogical study. Arterioscler Thromb Vasc Biol. 1997;17:3127-38.
14. Lahtinen A., Havulinna A., Jula A., et al. Prevalence and clinical correlates of familial hypercholesterolemiafounder mutations in the general population. Atherosclerosis. 2015;238:64-9.
15. Igonina N.A., Zhuravleva E.A., Kondrasheva E.A., et al. The cholesterol level in Russian adults aged 20-70 years. Ateroskleroz i Dislipidemii. 2012;4:69-73. (In Russ.) [Игонина Н.А., Журавлева Е.А., Кондрашева Е.А., Торшина И.Г., Чащихина Е.В., Макарова Т.А., Копаева Л.Б., Сысоева С.Н. Уровень холестерина в популяции взрослого населения РФ 20-70 лет. Атеросклероз и Дислипидемии. 2012;4:69-73].
Review
For citations:
Korneva V.А., Kuznetsova T.Yu., Tihova G.P. VARIABILITY IN LEVELS OF LOW-DENSITY LIPOPROTEINS CHOLESTEROL IN PATIENTS WITH FAMILIAL HYPERCHOLESTEROLEMIA DEPENDING ON AGE AND SEX AND ITS IMPORTANCE IN THE DIAGNOSIS OF THIS DISEASE. Rational Pharmacotherapy in Cardiology. 2017;13(1):36-44. (In Russ.) https://doi.org/10.20996/1819-6446-2017-13-1-36-44